NEURO61

Session information

[held on paper]Oral Session

[O-39] Oral Session 39
Neuroscience 2 E

Tomoko Toyota1, Zhe Huang2, Kazumasa Okada1, Toshiya Sato3, Shoji Tsuji4,5, Hiroaki Adachi1 (1.Department of Neurology, University of Occupational and Environmental Health School of Medicine, Japan, 2.Shanghai TCM-integrated Hospital, 3.Department of Laboratory Animal Science, Kitasato University School of Medicine, 4.Department of Neurology, International University of Health and Welfare, 5.Department of Molecular Neurology, University of Tokyo Graduate School of Medicine)

Yoshito Nagano1,2, Hitomi Obayashi1, Tetsuya Takahashi1, Takahiro Seki3, Shigeru Tanaka4, Norio Sakai4, Masayasu Matsumoto5, Hirofumi Maruyama1 (1.Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan, 2.Mitsubishi Tanabe Pharma, Japan, 3.Department of Chemico-Pharmacological Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, 4.Department of Molecular and Pharmacological Neuroscience, Graduate School of Biomedical & Health Sciences, Hiroshima University, 5.Sakai City Medical Center)

Daisuke Kodama1,2, Masakazu Tanaka1, Toshio Matsuzaki1,2,3, Satoshi Nozuma2,4, Eiji Matsuura2, Hiroshi Takashima2, Shuji Izumo1, Ryuji Kubota1 (1.Division of Neuroimmunology, Joint Research Center for Human Retrovirus Infection (Kagoshima University Campus), Japan, 2.Department of Neurology and Geriatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan, 3.Department of Neurology, Medical Corporation Sanshukai Ohkatsu Hospital, 4.Viral Immunology Section, Division of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States)

Tadanori Hamano1, Feiyan Zhu1,2, Gaoping Lin1,3, Ayumu Katsuki1, Hirohito Sasaki1, Soichi Enomoto1, Norimichi Shirafuji1, Asako Ueno1, Masamichi Ikawa1, Osamu Yamamura1, Nicholas M. Kanaan4, Shu-hui Yen5, Yasunari Nakamoto1 (1.Department of Neurology, Unviersity of Fukui, Japan, 2.Department of Neurology, Tongde Hospital of Zhejiang province, 3.Department of Neurology, Zhejiang Provincial People's Hospital, 4.Michigan State University, 5.Department of Neuroscience, Mayo Clinic Jacksonville)

Miho Uematsu1,2,3,4, Kyohei Mikami5, Ayako Nakamura1,6,7, Katsuiku Hirokawa8, Eijiro Adachi1, Ryosuke Takahashi2, Toshiki Uchihara1,6,7 (1.Laboratory of Structural Neuropathology, Tokyo Metropolitan Institute of Medical Science, Japan, 2.Department of Neurology, Kyoto University Graduate School of Medicine, Japan, 3.Department of Immunology and Genomics, Osaka City University Graduate School of Medicine, Japan, 4.Division of Innate immune regulation, International Research and Development Center for Mucosal Vaccine, Institute of Medical Science, The University of Tokyo, Japan, 5.Center for basic technology research, Tokyo Metropolitan Institute of Medical Science, 6.Department of neurology, Nitobe-Memorial Nakano General Hospital, 7.Department of Neurology and Neurological Science, Tokyo Medical and Dental University, 8.Department of pathology, Nitobe-Memorial Nakano General Hospital)